These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27986997)

  • 21. Outcome of Drug-Induced Parkinsonism in the Elderly: A Permanent Nonprogressive Parkinsonian Syndrome May Occur Following Discontinuation of Cinnarizine and Flunarizine.
    Calzetti S; Negrotti A
    Ann Pharmacother; 2024 Jul; ():10600280241263592. PubMed ID: 39054800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-induced parkinsonism: cinnarizine and flunarizine are potent uncouplers of the vacuolar H+-ATPase in catecholamine storage vesicles.
    Terland O; Flatmark T
    Neuropharmacology; 1999 Jun; 38(6):879-82. PubMed ID: 10465691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extrapyramidal and depressive side reactions with flunarizine and cinarizine.
    Mangone CA; Herskovits E
    J Neurol Neurosurg Psychiatry; 1989 Feb; 52(2):288-9. PubMed ID: 2703850
    [No Abstract]   [Full Text] [Related]  

  • 24. [Iatrogenic neurological disorders in old people: a review].
    Kuzuhara S
    Nihon Ronen Igakkai Zasshi; 2005 Jan; 42(1):21-4. PubMed ID: 15732350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between structure and drug-induced parkinsonism.
    Sawada Y; Nasu R; Matsuo H; Ohtani H
    Ann Pharmacother; 2000 May; 34(5):668. PubMed ID: 10852100
    [No Abstract]   [Full Text] [Related]  

  • 26. [Drug-induced or aggravated parkinsonism: clinical signs and the changing pattern of implicated drugs].
    Martí Massó JF; Poza JJ
    Neurologia; 1996 Jan; 11(1):10-5. PubMed ID: 8714170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-induced Parkinsonism: A strong predictor of idiopathic Parkinson's disease.
    Jeong S; Cho H; Kim YJ; Ma HI; Jang S
    PLoS One; 2021; 16(3):e0247354. PubMed ID: 33647030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flunarizine and cinnarizine inhibit mitochondrial complexes I and II: possible implication for parkinsonism.
    Veitch K; Hue L
    Mol Pharmacol; 1994 Jan; 45(1):158-63. PubMed ID: 8302275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flunarizine in the prevention of classical migraine: a placebo-controlled evaluation.
    Mendenopoulos G; Manafi T; Logothetis I; Bostantjopoulou S
    Cephalalgia; 1985 Mar; 5(1):31-7. PubMed ID: 3886152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasodilating effect of flunarizine in anesthetized dogs.
    Kato H; Kurihara J; Ishii K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):257-63. PubMed ID: 7224725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cinnarizine-induced parkinsonism: ten years later.
    Martí-Massó JF; Poza JJ
    Mov Disord; 1998 May; 13(3):453-6. PubMed ID: 9613736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A placebo-controlled, double-blind, cross-over trial of flunarizine in common migraine.
    Sørensen PS; Hansen K; Olesen J
    Cephalalgia; 1986 Mar; 6(1):7-14. PubMed ID: 3516409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Double-blind clinical study: flunarizine versus pizotifen in a single nightly dose in hemicrania patients].
    Cerbo R; Casacchia M; Formisano R; Buzzi MG; Boni B; Feliciani M; Grillo G; Cusimano G; Agnoli A
    Riv Neurol; 1985; 55(2):139-46. PubMed ID: 4012191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etiology of parkinsonism in a Brazilian movement disorders clinic.
    Cardoso F; Camargos ST; Silva Júnior GA
    Arq Neuropsiquiatr; 1998 Jun; 56(2):171-5. PubMed ID: 9698723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flunarizine-induced parkinsonism in the elderly.
    Benvenuti F; Baroni A; Bandinelli S; Ferrucci L; Corradetti R; Pantaleo T
    J Clin Pharmacol; 1988 Jul; 28(7):600-8. PubMed ID: 3216028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticonvulsive properties of cinnarizine and flunarizine in rats and mice.
    Desmedt LK; Niemegeers CJ; Janssen PA
    Arzneimittelforschung; 1975 Sep; 25(9):1408-13. PubMed ID: 1242663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of (E)-1-[bis (4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl) piperazine dihydrochloride(flunarizine) on cerebral circulation].
    Kubo K; Karasawa A; Yamada K; Nito M; Shuto K; Nakamizo N
    Nihon Yakurigaku Zasshi; 1982 May; 79(5):383-400. PubMed ID: 7129248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of the calcium channel blockers cinnarizine and flunarizine on the duration of hexobarbital-induced sleep i rats].
    Marazova KD; Lozeva VG; Belcheva-Beronova A
    Eksp Klin Farmakol; 1993; 56(2):16-8. PubMed ID: 8348027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of flunarizine in the treatment of tinnitus.
    Hulshof JH; Vermeij P
    ORL J Otorhinolaryngol Relat Spec; 1986; 48(1):33-6. PubMed ID: 3513083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flunarizine: a wide spectrum prophylactic for migraine headache.
    Micieli G; Sances G; Pacchetti C; Trucco M; Magri M; Piazza D
    Int J Clin Pharmacol Res; 1984; 4(3):239-45. PubMed ID: 6490242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.